Search concepts
|
Selected filters
|
- 1 - 25 out of 1,015 results
Search results
-
Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms
Kase, Y. & Okano, H., 12-2021, In: Inflammation and Regeneration. 41, 1, 15.Research output: Contribution to journal › Review article › peer-review
Open Access13 Citations (Scopus) -
Clinical utility of SARS-CoV-2 whole genome sequencing in deciphering source of infection
Keio Donner Project, 01-2021, In: Journal of Hospital Infection. 107, p. 40-44 5 p.Research output: Contribution to journal › Article › peer-review
Open Access19 Citations (Scopus) -
Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation
Nishitsuji, H., Iwahori, S., Ohmori, M., Shimotohno, K. & Murata, T., 08-2022, In: mBio. 13, 4Research output: Contribution to journal › Article › peer-review
Open Access36 Citations (Scopus) -
Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection during Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study)
Arashiro, T., Arima, Y., Muraoka, H., Sato, A., Oba, K., Uehara, Y., Arioka, H., Yanai, H., Kuramochi, J., Ihara, G., Chubachi, K., Yanagisawa, N., Nagura, Y., Kato, Y., Ueda, A., Numata, A., Kato, H., Ishii, K., Ooki, T. & Oka, H. & 6 others, , 01-02-2023, In: Clinical Infectious Diseases. 76, 3, p. E108-E115Research output: Contribution to journal › Article › peer-review
44 Citations (Scopus) -
Ensitrelvir treatment–emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial
Uehara, T., Yotsuyanagi, H., Ohmagari, N., Doi, Y., Yamato, M., Imamura, T., Sakaguchi, H., Fukushi, A., Takeda, Y., Baba, K., Nobori, H., Miyamoto, T., Arita, S., Dodo, R., Shimba, A., Fukao, K., Shishido, T., Tsuge, Y. & Mukae, H., 04-2025, In: Antiviral Research. 236, 106097.Research output: Contribution to journal › Article › peer-review
Open Access -
Temporal patterns of asymptomatic SARS-CoV-2 infection among pediatric population in Japan: A 3-year analysis
Kozawa, K., Higashimoto, Y., Kawamura, Y., Miura, H., Hattori, F., Mihara, Y., Nakai, H., Nishimura, N., Ozaki, T., Ihira, M. & Yoshikawa, T., 08-2024, In: Journal of Medical Virology. 96, 8, e29847.Research output: Contribution to journal › Article › peer-review
-
A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)
Yotsuyanagi, H., Ohmagari, N., Doi, Y., Imamura, T., Sonoyama, T., Ichihashi, G., Sanaki, T., Tsuge, Y., Uehara, T. & Mukae, H., 22-02-2023, In: Medicine (United States). 102, 8, p. E33024Research output: Contribution to journal › Article › peer-review
Open Access37 Citations (Scopus) -
Comparative analysis of antigen-specific anti-SARS-CoV-2 antibody isotypes in COVID-19 patients
Fujigaki, H., Inaba, M., Osawa, M., Moriyama, S., Takahashi, Y., Suzuki, T., Yamase, K., Yoshida, Y., Yagura, Y., Oyamada, T., Takemura, M., Doi, Y. & Saito, K., 15-05-2021, In: Journal of Immunology. 206, 10, p. 2393-2401 9 p.Research output: Contribution to journal › Article › peer-review
Open Access20 Citations (Scopus) -
Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan
Arashiro, T., Arima, Y., Kuramochi, J., Muraoka, H., Sato, A., Chubachi, K., Yanai, A., Arioka, H., Uehara, Y., Ihara, G., Kato, Y., Yanagisawa, N., Ueda, A., Kato, H., Oka, H., Nishida, Y., Nidaira, Y., Asami, T., Jinta, T. & Nakamura, A. & 12 others, , 01-06-2023, In: Open Forum Infectious Diseases. 10, 6, ofad240.Research output: Contribution to journal › Article › peer-review
12 Citations (Scopus) -
A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2
Koseki, T., Teramachi, M., Koga, M., Ko, M. S. H., Amano, T., Yu, H., Amano, M., Leyder, E., Badiola, M., Ray, P., Kim, J., Ko, A. C., Achour, A., Weng, N. P., Imai, T., Yoshida, H., Taniuchi, S., Shintani, A., Fujigaki, H. & Kondo, M. & 1 others, , 12-2023, In: Vaccines. 11, 12, 1767.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Breakthrough infections of e484k-harboring sars-cov-2 delta variant, lombardy, italy more articles on coronavirus, covid-19
Doi, Y., Ishii, K., Nishizono, A., Nanbo, A., Urata, S., Kurane, I., Celebrado, J. C., Depatillo, J. P., Bandola, Z., Griffin, D. E., Park, E. C., McDonald, D., Lu, K., Gayle Bernabe, K. & Handley, G., 10-2021, In: Emerging Infectious Diseases. 27, 10Research output: Contribution to journal › Article › peer-review
Open Access -
Differences in the incidence of nosocomial-onset COVID-19 among hospitalized patients with exposure to SARS-CoV-2
Nakagawa, M., Fujishiro, Y., Doi, Y., Yamakami, J. & Honda, H., 01-07-2024, In: Infection Control and Hospital Epidemiology. 45, 7, p. 903-905 3 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
The original strain of SARS-CoV-2, the Delta variant, and the Omicron variant infect microglia efficiently, in contrast to their inability to infect neurons: Analysis using 2D and 3D cultures
Kase, Y., Sonn, I., Goto, M., Murakami, R., Sato, T. & Okano, H., 05-2023, In: Experimental Neurology. 363, 114379.Research output: Contribution to journal › Article › peer-review
Open Access18 Citations (Scopus) -
Reliability of serological tests for COVID-19: comparison of three immunochromatography test kits for SARS-CoV-2 antibodies
Fujigaki, H., Takemura, M., Osawa, M., Sakurai, A., Nakamoto, K., Seto, K., Fujita, T., Hata, T., Akiyama, H., Doi, Y. & Saito, K., 09-2020, In: Heliyon. 6, 9, e04929.Research output: Contribution to journal › Article › peer-review
Open Access14 Citations (Scopus) -
Behavioral factors associated with SARS-CoV-2 infection in Japan
Arashiro, T., Arima, Y., Muraoka, H., Sato, A., Oba, K., Uehara, Y., Arioka, H., Yanai, H., Yanagisawa, N., Nagura, Y., Kato, Y., Kato, H., Ueda, A., Ishii, K., Ooki, T., Oka, H., Nishida, Y., Stucky, A., Miyahara, R. & Smith, C. & 3 others, , 09-2022, In: Influenza and other Respiratory Viruses. 16, 5, p. 952-961 10 p.Research output: Contribution to journal › Article › peer-review
14 Citations (Scopus) -
Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2
Fujigaki, H., Yamamoto, Y., Koseki, T., Banno, S., Ando, T., Ito, H., Fujita, T., Naruse, H., Hata, T., Moriyama, S., Takahashi, Y., Suzuki, T., Murakami, T., Yoshida, Y., Yagura, Y., Oyamada, T., Takemura, M., Kondo, M., Iwata, M. & Saito, K., 02-2022, In: Microbiology spectrum. 10, 1, e01181-21.Research output: Contribution to journal › Article › peer-review
Open Access21 Citations (Scopus) -
Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers
Murata, T., Sakurai, A., Suzuki, M., Komoto, S., Ide, T., Ishihara, T. & Doi, Y., 05-2021, In: mSphere. 6, 3, p. 1-7 7 p., e00019-21.Research output: Contribution to journal › Article › peer-review
Open Access25 Citations (Scopus) -
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part
Mukae, H., Yotsuyanagi, H., Ohmagari, N., Doi, Y., Imamura, T., Sonoyama, T., Fukuhara, T., Ichihashi, G., Sanaki, T., Baba, K., Takeda, Y., Tsuge, Y. & Uehara, T., 10-2022, In: Antimicrobial agents and chemotherapy. 66, 10Research output: Contribution to journal › Article › peer-review
Open Access87 Citations (Scopus) -
Immune response against SARS-CoV-2 in pediatric patients including young infants
Kawamura, Y., Higashimoto, Y., Miura, H., Ihira, M., Inaba, M., Ito, R., Kozawa, K. & Yoshikawa, T., 03-2021, In: Journal of Medical Virology. 93, 3, p. 1776-1779 4 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Natural History of Asymptomatic SARS-CoV-2 Infection
Sakurai, A., Sasaki, T., Kato, S., Hayashi, M., Tsuzuki, S. I., Ishihara, T., Iwata, M., Morise, Z. & Doi, Y., 27-08-2020, In: New England Journal of Medicine. 383, 9Research output: Contribution to journal › Letter › peer-review
Open Access211 Citations (Scopus) -
Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19
Keio Donner Project, 12-2022, In: Scientific reports. 12, 1, 1299.Research output: Contribution to journal › Article › peer-review
Open Access17 Citations (Scopus) -
Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity
Iwamura, C., Hirahara, K., Kiuchi, M., Ikehara, S., Azuma, K., Shimada, T., Kuriyama, S., Ohki, S., Yamamoto, E., Inaba, Y., Shiko, Y., Aoki, A., Kokubo, K., Hirasawa, R., Hishiya, T., Tsuji, K., Nagaoka, T., Ishikawa, S., Kojima, A. & Mito, H. & 29 others, , 16-08-2022, In: Proceedings of the National Academy of Sciences of the United States of America. 119, 33, e2203437119.Research output: Contribution to journal › Article › peer-review
17 Citations (Scopus) -
Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population
Dijkstra, J. M. & Hashimoto, K., 2020, In: F1000Research. 9, 285.Research output: Contribution to journal › Article › peer-review
Open Access16 Citations (Scopus) -
Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models
Takeshita, M., Fukuyama, H., Kamada, K., Matsumoto, T., Makino-Okamura, C., Uchikubo-Kamo, T., Tomabechi, Y., Hanada, K., Moriyama, S., Takahashi, Y., Ishigaki, H., Nakayama, M., Nguyen, C. T., Kitagawa, Y., Itoh, Y., Imai, M., Maemura, T., Furusawa, Y., Ueki, H. & Iwatsuki-Horimoto, K. & 11 others, , 22-12-2022, In: iScience. 25, 12, 105596.Research output: Contribution to journal › Article › peer-review
Open Access10 Citations (Scopus) -
Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
for the Keio Donner Project, 05-2022, In: Clinical Immunology. 238, 108999.Research output: Contribution to journal › Article › peer-review
Open Access9 Citations (Scopus)